Annexin Pharmaceuticals AB (OSTO:ANNX) Total Liabilities: kr5.56 Mil (As of Mar. 2026)


OSTO:ANNX Annexin Pharmaceuticals AB OSTO:ANNX
23 GF Score
Price kr13.00
! 1 Warning Sign
View Full Analysis

What is Annexin Pharmaceuticals AB Total Liabilities?

Annexin Pharmaceuticals AB OSTO:ANNX +4.00% 23 Total Liabilities is kr5.56 Mil as of Mar. 2026. GuruFocus rates OSTO:ANNX with a GF Score™ of 23/100. The stock has 1 warning sign investors should review.

Annexin Pharmaceuticals AB's Total Liabilities for the quarter that ended in Mar. 2026 was kr5.56 Mil.

Annexin Pharmaceuticals AB's quarterly Total Liabilities increased from Sep. 2025 (kr4.06 Mil) to Dec. 2025 (kr5.22 Mil) and increased from Dec. 2025 (kr5.22 Mil) to Mar. 2026 (kr5.56 Mil).

Annexin Pharmaceuticals AB's annual Total Liabilities declined from Dec. 2023 (kr7.95 Mil) to Dec. 2024 (kr5.32 Mil) and declined from Dec. 2024 (kr5.32 Mil) to Dec. 2025 (kr5.22 Mil).

Annexin Pharmaceuticals AB Total Liabilities Historical Data

* Premium members only.

The historical data trend for Annexin Pharmaceuticals AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Annexin Pharmaceuticals AB Total Liabilities Chart

Annexin Pharmaceuticals AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.06 6.53 7.95 5.32 5.22

Annexin Pharmaceuticals AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.13 3.74 4.06 5.22 5.56
OSTO:ANNX
23GF Score
Annexin Pharmaceuticals AB OSTO:ANNX
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Annexin Pharmaceuticals AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Annexin Pharmaceuticals AB's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.224+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=5.22

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=30.156-24.932
=5.22

Annexin Pharmaceuticals AB's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.563+(0+-0.00099999999999945
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=5.56

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=19.978-14.416
=5.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of kr5.56 Mil mean?
Annexin Pharmaceuticals AB (OSTO:ANNX) has a Total Liabilities of kr5.56 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Annexin Pharmaceuticals AB and its competitors.
Is Annexin Pharmaceuticals AB's Total Liabilities too high?
Annexin Pharmaceuticals AB's current Total Liabilities is kr5.56 Mil. Overall, Annexin Pharmaceuticals AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Annexin Pharmaceuticals AB's Total Liabilities compare to VRTX and REGN?
Annexin Pharmaceuticals AB's Total Liabilities of kr5.56 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Annexin Pharmaceuticals AB and its competitors. Annexin Pharmaceuticals AB's current Total Liabilities is kr5.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annexin Pharmaceuticals AB stock overvalued right now?
Annexin Pharmaceuticals AB (OSTO:ANNX) has a current Total Liabilities of kr5.56 Mil. The current Total Liabilities is kr5.56 Mil. Annexin Pharmaceuticals AB's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Annexin Pharmaceuticals AB (OSTO:ANNX), the current Total Liabilities is kr5.56 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Annexin Pharmaceuticals AB Business Description

Other Exchanges Q910:Germany
Address Kammakargatan 48, Stockholm, SWE, 111 60
Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.
23GF Score

Get the complete analysis for OSTO:ANNX

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr13.00
Price